Cher.V
CHER.V operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
Business. CHER.V operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
CHER.V operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
CHER.V's capital structure is characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidity position is reflected in a current ratio of 2.78, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's liquidity risk is assessed as low, with no immediate filing-based liquidity flags detected.
Profitability metrics for CHER.V are negative, with a return on equity of -0.9799 and a return on assets of -0.6276. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating and net income are both negative at -65,970 CAD, further highlighting the company's unprofitable operations.
CHER.V's revenue concentration is not disclosed in the available data, but the company's operations are primarily focused on the healthcare services and equipment industry. There is no information provided on geographic exposure or segment-specific revenue contributions.
The company's growth trajectory is not clearly defined, as there are no numeric deltas provided for the current or next fiscal year. The negative operating and net income figures suggest a lack of growth and potential financial distress.
Risk factors for CHER.V include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's dilution potential is assessed as low, and no adjustments have been applied to the valuation metrics. However, the negative financial performance indicates potential operational and financial risks.
Recent events and filings for CHER.V do not show any significant developments or disclosures that would impact the company's financial position or operations.
- CHER.V has a debt-free capital structure but is currently unprofitable with negative returns on equity and assets.
- The company's liquidity position is strong, with a current ratio of 2.78, but its profitability is a major concern.
- There is no immediate liquidity or dilution risk, but the negative financial performance suggests potential operational challenges.
- The company's growth trajectory is unclear, and there are no disclosed segment or geographic revenue concentrations.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- CHER.V Market data — financials · 2026-05-27